Drug intelligence / Profile preview

Innobiotica

Development stage: Unknown
Lead developer: Weber & Weber
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Innobiotica is a probiotic dietary supplement developed and marketed by the German company Weber & Weber. It is formulated as a multi-strain complex containing several species of lactic acid bacteria, including *Lactobacillus acidophilus*, *Bifidobacterium lactis*, *Enterococcus faecium*, *Lactobacillus casei*, *Lactobacillus salivarius*, and *Lactococcus lactis*. The product is primarily indicated for the maintenance of a healthy intestinal flora and the support of the immune system, particularly in contexts such as antibiotic-associated dysbiosis. As a probiotic, it functions by replenishing beneficial microorganisms in the gut, thereby inhibiting the growth of pathogenic bacteria and promoting a balanced microbiome.

Brand names: Innobiotica

Beyond the preview

Go deeper on Innobiotica.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innobiotica.

Explore the full profile